Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorder

Lorcaserin treatment for extended-release naltrexone induction and retention for opioid use disorder individuals: A pilot, placebo-controlled randomized trial

(2021) Frances R. Levin et al.   DRUG AND ALCOHOL DEPENDENCE

Lofexidine versus clonidine for mitigation of opioid withdrawal symptoms: A systematic review

(2019) Amanda K. Kuszmaul et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

A week-long outpatient induction onto XR-naltrexone in patients with opioid use disorder

(2019) Mohammad Sibai et al.   AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE

Extended-release injectable naltrexone for opioid use disorder: a systematic review

(2018) Brantley P. Jarvis et al.   ADDICTION

Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial

(2018) Adam Bisaga et al.   DRUG AND ALCOHOL DEPENDENCE

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial

(2018) Joshua D Lee et al.   LANCET

Safety and Efficacy of Lofexidine for Medically Managed Opioid Withdrawal

(2018) Marc Fishman et al.   Journal of Addiction Medicine

Fentanyl: Receptor pharmacology, abuse potential, and implications for treatment

(2018) Sandra D. Comer et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Opioid use and dropout in patients receiving oral naltrexone with or without single administration of injection naltrexone

(2015) Maria A. Sullivan et al.   DRUG AND ALCOHOL DEPENDENCE

The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone

(2015) Adam Bisaga et al.   DRUG AND ALCOHOL DEPENDENCE

Opioid Detoxification and Naltrexone Induction Strategies: Recommendations for Clinical Practice

(2012) Stacey C. Sigmon et al.   AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE

A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependence

(2011) Adam Bisaga et al.   DRUG AND ALCOHOL DEPENDENCE